Your browser doesn't support javascript.
loading
Tocilizumab treatment in COVID-19: A prognostic study using propensity score matching.
Güçlü, Özge Aydin; Önal, Ugur; Akalin, Halis; Öztürk, Nilüfer Aylin Acet; Belik, Hazel Öztürk; Demirdögen, Ezgi; Dilektasli, Asli Görek; Kazak, Esra; Ocakoglu, Gökhan; Saglik, Imran; Coskun, Funda; Ediger, Dane; Heper, Yasemin; Ursavas, Ahmet; Yilmaz, Emel; Uzaslan, Esra; Karadag, Mehmet.
Afiliación
  • Güçlü ÖA; Faculty of Medicine, Bursa Uludag University, Turkey.
  • Önal U; Faculty of Medicine, Bursa Uludag University, Turkey.
  • Akalin H; Faculty of Medicine, Bursa Uludag University, Turkey.
  • Öztürk NAA; Faculty of Medicine, Bursa Uludag University, Turkey.
  • Belik HÖ; Faculty of Medicine, Bursa Uludag University, Turkey.
  • Demirdögen E; Faculty of Medicine, Bursa Uludag University, Turkey.
  • Dilektasli AG; Faculty of Medicine, Bursa Uludag University, Turkey.
  • Kazak E; Faculty of Medicine, Bursa Uludag University, Turkey.
  • Ocakoglu G; Faculty of Medicine, Bursa Uludag University, Turkey.
  • Saglik I; Faculty of Medicine, Bursa Uludag University, Turkey.
  • Coskun F; Faculty of Medicine, Bursa Uludag University, Turkey.
  • Ediger D; Faculty of Medicine, Bursa Uludag University, Turkey.
  • Heper Y; Faculty of Medicine, Bursa Uludag University, Turkey.
  • Ursavas A; Faculty of Medicine, Bursa Uludag University, Turkey.
  • Yilmaz E; Faculty of Medicine, Bursa Uludag University, Turkey.
  • Uzaslan E; Faculty of Medicine, Bursa Uludag University, Turkey.
  • Karadag M; Faculty of Medicine, Bursa Uludag University, Turkey.
Adv Clin Exp Med ; 31(11): 1197-1206, 2022 Nov.
Article en En | MEDLINE | ID: mdl-35951629

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Adv Clin Exp Med Año: 2022 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Adv Clin Exp Med Año: 2022 Tipo del documento: Article País de afiliación: Turquía